DR. BORIS D RATINER M.D. NPI 1821001496

NPI Information

  • NPI: 1821001496
  • Provider Name: DR. BORIS D RATINER, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • CLIA Number: 05D0558190
  • Address: 18386 VENTURA BLVD
    TARZANA, CA
    ZIP 91356
  • Phone: (818) 996-4077

Map and Directions

Get Directions

NPI Details

DR. Boris D Ratiner, M.D. is a rheumatology internal medicine in Tarzana, CA with 32 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Boris D Ratiner, M.D. NPI is 1821001496. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Graduation Year:1994

The provider's business location address is:

18386 VENTURA BLVD
TARZANA, CA
ZIP 91356-219
Phone: (818) 996-4077
Fax: (818) 996-4069

The NPI 1821001496 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D0558190 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg (HCPCS:J7318)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood creatinine level (HCPCS:82565)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Blood glucose (sugar) level (HCPCS:82947)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
  • Blood potassium level (HCPCS:84132)
  • Blood sodium level (HCPCS:84295)
  • Uric acid level, blood (HCPCS:84550)
  • Vitamin d-3 level (HCPCS:82306)
  • Amylase (enzyme) level (HCPCS:82150)
  • Albumin (protein) level (HCPCS:82040)
  • Bilirubin level, total (HCPCS:82247)
  • Total protein level, blood (HCPCS:84155)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Osteocalcin (bone protein) level (HCPCS:83937)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection of trigger points, 3 or more muscles (HCPCS:20553)
  • Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative (HCPCS:86328)
  • X-ray of knee, 3 views (HCPCS:73562)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Rheumatoid factor level (HCPCS:86431)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • X-ray of wrist, minimum of 3 views (HCPCS:73110)
  • Tuberculosis test, enumeration of t-cells (HCPCS:86481)
  • Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Iron level (HCPCS:83540)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Magnesium level (HCPCS:83735)
  • Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Ultrasonic guidance for needle placement (HCPCS:76942)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • X-ray of ankle, minimum of 3 views (HCPCS:73610)
  • Injection into tendon at attachment to bone or muscle (HCPCS:20551)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • X-ray of both hips, 3-4 views (HCPCS:73522)
  • Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
  • X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Hyaluronan or derivative, monovisc, for intra-articular injection, per dose (HCPCS:J7327)
  • Injection into tendon or ligament (HCPCS:20550)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99487)

The enumeration date for this NPI number is 8/14/2006 and was last updated on 1/9/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyA60202CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
100A602020MEDICAIDCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.